The examined markers are CD56, CD57, WT1, AMACR, KRT7, and KRTAE1/AE3, which assist to separate nephroblastoma with epithelial predominance from morphologically indistinguishable metanephric adenoma. This evidence concerns the gene SLC4A3 and Nephroblastoma.